Literature DB >> 10813272

HLA-B27 misfolding and spondyloarthropathies: not so groovy after all?

R A Colbert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10813272

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  6 in total

Review 1.  Predisposing factors in the spondyloarthropathies: new insights into the role of HLA-B27.

Authors:  R A Colbert; S Prahalad
Journal:  Curr Rheumatol Rep       Date:  2001-10       Impact factor: 4.592

Review 2.  Insights into the Role of Infection in the Spondyloarthropathies.

Authors:  Y Liu; M A Penttinen; K Granfors
Journal:  Curr Rheumatol Rep       Date:  2001-10       Impact factor: 4.592

Review 3.  The role of infection in the pathogenesis of spondyloarthropathies with special reference to human leukocyte antigen-B27.

Authors:  Markus A Penttinen; Yi Liu; Kaisa Granfors
Journal:  Curr Rheumatol Rep       Date:  2002-12       Impact factor: 4.592

4.  HLA-B27-transfected (Salmonella permissive) and HLA-A2-transfected (Salmonella nonpermissive) human monocytic U937 cells differ in their production of cytokines.

Authors:  Päivi Ekman; Marja Saarinen; Qiushui He; Christel Gripenberg-Lerche; Alvar Grönberg; Heikki Arvilommi; Kaisa Granfors
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

5.  Pathogenicity of Misfolded and Dimeric HLA-B27 Molecules.

Authors:  Antony N Antoniou; Izabela Lenart; David B Guiliano
Journal:  Int J Rheumatol       Date:  2011-03-30

6.  Intrinsic Folding Properties of the HLA-B27 Heavy Chain Revealed by Single Chain Trimer Versions of Peptide-Loaded Class I Major Histocompatibility Complex Molecules.

Authors:  Izabela Lenart; Linh-Huyen Truong; Dinh Dung Nguyen; Olga Rasiukienė; Edward Tsao; Jonathan Armstrong; Pankaj Kumar; Kirsty McHugh; Branca I Pereira; Balraj S Maan; Malgorzata A Garstka; Paul Bowness; Neil Blake; Simon J Powis; Keith Gould; Darren Nesbeth; Antony N Antoniou
Journal:  Front Immunol       Date:  2022-07-25       Impact factor: 8.786
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.